PDF(Pubmed)
Abstract：
UNASSIGNED: This study evaluates the impact of Real-Time Prescription Benefits (RTPB), a tool integrated into electronic health records (EHRs), on patient out-of-pocket costs in an academic institution. RTPB provides prescribers with alternative, less expensive medications based on insurance plans. The primary measure was cost-savings, defined as the difference between the out-of-pocket cost of the prescribed medication and its alternative.
UNASSIGNED: A retrospective analysis of prescriptions from outpatient clinics in a university-based health system was conducted between May 2020 and July 2021. Prescriptions were analyzed at the 2nd level of the Anatomical Therapeutic Chemical (ATC) classification system. Costs were standardized to a 30-day supply. Standardized cost and total cost per prescription, and overall savings for the top 20 medication classes at the 2nd ATC level were calculated. The overall impact of RTPB was estimated based on selecting the least expensive alternative suggested by RTPB.
UNASSIGNED: The study found that RTPB information was provided for 22% of prescriptions, with suggested alternatives for 1.26%. Among prescriptions with an alternative selected, the standardized average cost saving was $38.83. The study realized $15,416 in patient total cost savings. If the least expensive RTPB-suggested alternative were chosen for all prescriptions, an estimated $276,386 could have been saved. Psychoanaleptic and psycholeptic medications were the most prescribed with an alternative, with most savings in specialty drugs like anthelmintic and immunostimulant medications.
UNASSIGNED: The study highlights the importance of RTPB in reducing patient costs. It reports patient cost-savings with RTPB in prescribing decisions. Future research could explore the impact of RTPB on medication adherence using pharmacy claims data.
UNASSIGNED: A retrospective analysis of prescriptions from outpatient clinics in a university-based health system was conducted between May 2020 and July 2021. Prescriptions were analyzed at the 2nd level of the Anatomical Therapeutic Chemical (ATC) classification system. Costs were standardized to a 30-day supply. Standardized cost and total cost per prescription, and overall savings for the top 20 medication classes at the 2nd ATC level were calculated. The overall impact of RTPB was estimated based on selecting the least expensive alternative suggested by RTPB.
UNASSIGNED: The study found that RTPB information was provided for 22% of prescriptions, with suggested alternatives for 1.26%. Among prescriptions with an alternative selected, the standardized average cost saving was $38.83. The study realized $15,416 in patient total cost savings. If the least expensive RTPB-suggested alternative were chosen for all prescriptions, an estimated $276,386 could have been saved. Psychoanaleptic and psycholeptic medications were the most prescribed with an alternative, with most savings in specialty drugs like anthelmintic and immunostimulant medications.
UNASSIGNED: The study highlights the importance of RTPB in reducing patient costs. It reports patient cost-savings with RTPB in prescribing decisions. Future research could explore the impact of RTPB on medication adherence using pharmacy claims data.
摘要：
■本研究评估了实时处方福利(RTPB)的影响，集成到电子健康记录(EHR)中的工具，在学术机构的病人自付费用。RTPB为处方者提供了替代方案，基于保险计划的较便宜的药物。主要措施是节约成本，定义为处方药的自付费用与其替代品之间的差额。
■在2020年5月至2021年7月之间，对大学卫生系统中门诊诊所的处方进行了回顾性分析。在解剖治疗化学（ATC）分类系统的第二级分析处方。成本被标准化为30天的供应。每个处方的标准化成本和总成本，并计算了第二ATC级别前20种药物的总体节省。基于选择RTPB建议的最便宜的替代方案来估计RTPB的总体影响。
■研究发现，22%的处方提供了RTPB信息，建议的替代品为1.26%。在选择了替代方案的处方中，标准化的平均成本节约为38.83美元。该研究实现了15,416美元的患者总成本节省。如果为所有处方选择了最便宜的RTPB建议的替代方案，估计可以节省276,386美元。精神敏感和精神敏感药物是处方最多的替代药物，在驱虫药和免疫刺激药物等特殊药物上节省了大部分。
■该研究强调了RTPB在降低患者成本方面的重要性。它报告在处方决策中使用RTPB节省的患者成本。未来的研究可以使用药房索赔数据探索RTPB对药物依从性的影响。
■在2020年5月至2021年7月之间，对大学卫生系统中门诊诊所的处方进行了回顾性分析。在解剖治疗化学（ATC）分类系统的第二级分析处方。成本被标准化为30天的供应。每个处方的标准化成本和总成本，并计算了第二ATC级别前20种药物的总体节省。基于选择RTPB建议的最便宜的替代方案来估计RTPB的总体影响。
■研究发现，22%的处方提供了RTPB信息，建议的替代品为1.26%。在选择了替代方案的处方中，标准化的平均成本节约为38.83美元。该研究实现了15,416美元的患者总成本节省。如果为所有处方选择了最便宜的RTPB建议的替代方案，估计可以节省276,386美元。精神敏感和精神敏感药物是处方最多的替代药物，在驱虫药和免疫刺激药物等特殊药物上节省了大部分。
■该研究强调了RTPB在降低患者成本方面的重要性。它报告在处方决策中使用RTPB节省的患者成本。未来的研究可以使用药房索赔数据探索RTPB对药物依从性的影响。
